ASK REDCHAT ANYTHING ABOUT FRACTYL HEALTH INC.
Fractyl Health Inc. (NASDAQ: GUTS)
Listen to this Section
$0.67
-0.0646
(
-8.81% )
2.3M
Sign up for The Small Stocks Big Money Newsletter and receive free small-cap news and insights.
Clinical Trial Pipeline Stages
| Drug Name |
Stage |
| RevitaDetailsObesity, Type 2 diabetes |
Phase 1 |
Market Data
|
| Open |
$0.67 |
| Previous Close |
$0.73 |
| Volume |
2.3M |
| Market Cap |
$120.57M |
| Day Range |
$0.66 - $0.77 |
| 52 Week Range |
$0.38 - $3.03 |
| Shares Outstanding |
158.65M |
| Change % |
-8.81% |
| Net Change |
▼ -0.0646 |
| Insider Ownership |
-0.05% |
| Exchange |
NASDAQ |
| Sector | Healthcare |
| Industry | |
| IPO Year | 2024 |
| Country | United States |
| Underwriter | BofA Securities, Morgan Stanley, Evercore ISI, more |
Insider Ownership Transactions
Total Amount Purchased:
2,350,947.00
| Date |
Type |
Amount Purchased |
Purchaser |
| 2024-02-08 |
Sale |
-4702161.00 |
General Catalyst GP V, LLC |
| 2024-02-08 |
Buy |
1389451.00 |
Elia Marc |
| 2024-02-08 |
Sale |
-4770901.00 |
Bessemer Venture Partners VII L.P. |
| 2024-02-06 |
Buy |
3419876.00 |
CVF, LLC |
| 2024-02-05 |
Sale |
-45000.00 |
MEANWELL CLIVE |
| 2024-02-05 |
Sale |
-45000.00 |
Will Allan R |
| 2024-02-05 |
Sale |
-45000.00 |
Royan Ajay |
| 2024-02-05 |
Sale |
-45000.00 |
Conaway Samuel |
| 2024-02-05 |
Sale |
-45000.00 |
BRADLEY WILLIAM |
| 2024-02-05 |
Sale |
-45000.00 |
Elia Marc |
SEC Filings
| Form Type |
Description |
Pages |
Date |
| schedule |
Other |
1 |
Nov 14, 2025 |
| schedule |
Other |
1 |
Nov 14, 2025 |
| schedule |
Other |
1 |
Nov 14, 2025 |
| schedule |
Other |
1 |
Nov 14, 2025 |
| 10-q |
Quarterly Reports |
66 |
Nov 12, 2025 |
| 8-k |
8K-related |
12 |
Nov 12, 2025 |
| 8-k |
8K-related |
10 |
Oct 03, 2025 |
| 8-k |
8K-related |
36 |
Sep 26, 2025 |
| 8-k |
8K-related |
17 |
Sep 26, 2025 |
| 3 |
Insider transactions |
2 |
Sep 04, 2025 |